Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients
Open Access
- 27 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 57 (7), 1212-1221
- https://doi.org/10.1093/rheumatology/key060
Abstract
To identify initial predictors of poor survival in patients with PM/DM-associated interstitial lung disease (ILD). We established a multicentre retrospective cohort of incident cases of PM/DM-associated ILD from 44 institutions across Japan (Multicentre Retrospective Cohort of Japanese Patients with Myositis-associated ILD, JAMI). Inclusion criteria were an onset age ⩾16 years; PM/DM or clinically amyopathic DM according to the published criteria; imaging evidence of ILD; and availability of serum samples for assays of autoantibodies such as anti-melanoma differentiation-associated gene 5 and anti-aminoacyl tRNA synthetase. We collected demographic data and clinical characteristics recorded at the time of diagnosis, as well as follow-up survival data. Predictors of ILD-related mortality were identified by univariate and multivariate analyses. JAMI enrolled a cohort of 497 patients with PM (15%), classic DM (32%) and clinically amyopathic DM (53%). During the observation period (median 20 months), 76 died of respiratory insufficiency directly related to ILD. Univariate analysis revealed several initial parameters associated with ILD mortality, including demographic, clinical, laboratory, imaging and autoantibody variables. We used multivariate analysis with a stepwise selection of parameters to generate an appropriate predictive model, and identified the following independent risk factors for ILD mortality: age at onset ⩾60 years [hazard ratio (HR) = 4.3, 95% CI: 2.4, 7.5], CRP ⩾1 mg/dl (HR = 2.6, 95% CI: 1.5, 4.8), peripheral capillary oxygen saturation <95% (HR = 2.0, 95% CI: 1.2, 3.4) and anti-melanoma differentiation-associated gene 5 antibody (HR = 7.5, 95% CI: 2.8, 20.2). We established a large cohort of incident cases of PM/DM-associated ILD, and successfully identified independent predictors of short-term ILD mortality.Keywords
This publication has 42 references indexed in Scilit:
- The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DMRheumatology, 2012
- Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and TreatmentCurrent Rheumatology Reports, 2012
- HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibodyRespiratory Medicine, 2011
- A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory MyopathiesRheumatology, 2010
- Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositisRheumatology, 2010
- RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung diseaseArthritis & Rheumatism, 2009
- Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/DermatomyositisLung, 2009
- Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositisArthritis & Rheumatism, 2005
- Clinical Features of Polymyositis/Dermatomyositis with Steroid-Resistant Interstitial Lung Disease.Internal Medicine, 1998
- Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extractsArthritis & Rheumatism, 1985